Moreover, we employed Gene Set Enrichment Analysis (GSEA) to investigate the expression of IL8RB in prostate cancer (PRAD), and ELISA to verify the findings in patients recruited from our centers. This evidence concerns the gene CXCR2 and prostate cancer.